Han B - Search Results

1

Transcriptomic profiling of mice brain under Bex3 regulation.

Xu Z, Bahadar N, Zhang Y, Tan S, Wang Z, Ren B, Liu S, Dai H, Zheng Y, Han B. Xu Z, et al. Among authors: han b. Turk J Biol. 2021 Nov 24;46(1):57-68. doi: 10.3906/biy-2108-96. eCollection 2022. Turk J Biol. 2021. PMID: 37533672 Free PMC article.

2

Intranasal Delivery of Targeted Nanoparticles Loaded With miR-132 to Brain for the Treatment of Neurodegenerative Diseases.

Su Y, Sun B, Gao X, Dong X, Fu L, Zhang Y, Li Z, Wang Y, Jiang H, Han B. Su Y, et al. Among authors: han b. Front Pharmacol. 2020 Aug 6;11:1165. doi: 10.3389/fphar.2020.01165. eCollection 2020. Front Pharmacol. 2020. PMID: 32848773 Free PMC article.

3

RGD-PEG-PLA Delivers MiR-133 to Infarct Lesions of Acute Myocardial Infarction Model Rats for Cardiac Protection.

Sun B, Liu S, Hao R, Dong X, Fu L, Han B. Sun B, et al. Among authors: han b. Pharmaceutics. 2020 Jun 21;12(6):575. doi: 10.3390/pharmaceutics12060575. Pharmaceutics. 2020. PMID: 32575874 Free PMC article.

4

Chitosan Hydrogel Doped with PEG-PLA Nanoparticles for the Local Delivery of miRNA-146a to Treat Allergic Rhinitis.

Su Y, Sun B, Gao X, Liu S, Hao R, Han B. Su Y, et al. Among authors: han b. Pharmaceutics. 2020 Sep 23;12(10):907. doi: 10.3390/pharmaceutics12100907. Pharmaceutics. 2020. PMID: 32977497 Free PMC article.

5

In vitro characterization of pH-sensitive Bletilla Striata polysaccharide copolymer micelles and enhanced tumour suppression in vivo.

Zhao L, Sun D, Lu H, Han B, Zhang G, Guan Q. Zhao L, et al. Among authors: han b. J Pharm Pharmacol. 2018 Jun;70(6):797-807. doi: 10.1111/jphp.12888. Epub 2018 Feb 27. J Pharm Pharmacol. 2018. PMID: 29485227

6

Cationic lipid-assisted nanoparticles for simultaneous delivery of CD47 siRNA and R848 to promote antitumor immune responses.

Li S, Chen Y, Ma R, Du Y, Han B. Li S, et al. Among authors: han b. Front Pharmacol. 2023 Mar 31;14:1142374. doi: 10.3389/fphar.2023.1142374. eCollection 2023. Front Pharmacol. 2023. PMID: 37063284 Free PMC article.

7

A personalized biomimetic dual-drug delivery system via controlled release of PTH_1-34 and simvastatin for in situ osteoporotic bone regeneration.

Xu T, Gao S, Yang N, Zhao Q, Zhang Y, Li T, Liu Z, Han B. Xu T, et al. Among authors: han b. Front Bioeng Biotechnol. 2024 Jan 31;12:1355019. doi: 10.3389/fbioe.2024.1355019. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38357710 Free PMC article.

8

Luteolin Protects Against CIRI, Potentially via Regulation of the SIRT3/AMPK/mTOR Signaling Pathway.

Liu S, Su Y, Sun B, Hao R, Pan S, Gao X, Dong X, Ismail AM, Han B. Liu S, et al. Among authors: han b. Neurochem Res. 2020 Oct;45(10):2499-2515. doi: 10.1007/s11064-020-03108-w. Epub 2020 Aug 18. Neurochem Res. 2020. PMID: 32809175

9

Treatment of Netherton syndrome with upadacitinib.

Li X, Han B, Li S. Li X, et al. Among authors: han b. Clin Exp Dermatol. 2023 Nov 16;48(12):1379-1381. doi: 10.1093/ced/llad242. Clin Exp Dermatol. 2023. PMID: 37477382 No abstract available.

10

High pressure investigations on TTF-TCNQ charge-transfer complexes.

Han B, Ma R, Wang H, Zhou M. Han B, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2022 Feb 15;267(Pt 1):120541. doi: 10.1016/j.saa.2021.120541. Epub 2021 Oct 28. Spectrochim Acta A Mol Biomol Spectrosc. 2022. PMID: 34740004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,323 results

Search Page